Definition and classification of cancer cachexia: An international consensus

The Lancet Oncology

Volumn 12, Issue 5, 2011, Pages 489-495

  Fearon, Kenneth ^a   Strasser, Florian ^b   Anker, Stefan D ^c,d   Bosaeus, Ingvar ^e   Bruera, Eduardo ^f   Fainsinger, Robin L ^g   Jatoi, Aminah ^h   Loprinzi, Charles ^h   MacDonald, Neil ⁱ   Mantovani, Giovanni ^j   Davis, Mellar ^k   Muscaritoli, Maurizio ^l   Ottery, Faith ^m   Radbruch, Lukas ⁿ   Ravasco, Paula ^o   Walsh, Declan ^k   Wilcock, Andrew ^p   Kaasa, Stein ^q   Baracos, Vickie E ^q  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Kantonsspital St Gallen Division of Oncology Haematology   (Switzerland)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g UNIVERSITY OF ALBERTA   (Canada)

^h MAYO CLINIC   (United States)

ⁱ MCGILL UNIVERSITY   (Canada)

^j UNIVERSITY OF CAGLIARI   (Italy)

^k LERNER RESEARCH INSTITUTE   (United States)

^l SAPIENZA UNIVERSITY OF ROME   (Italy)

^m Oncology Care Consultants   (United States)

ⁿ UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^o INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES   (Portugal)

^p NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^q NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

ANOREXIA; CACHEXIA; CANCER CACHEXIA; CATABOLISM; CLINICAL STUDY; CONSENSUS; DELPHI STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENERGY BALANCE; FOOD INTAKE; FUNCTIONAL DISEASE; HUMAN; INFORMATION PROCESSING; METABOLIC DISORDER; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE STRENGTH; NUTRITIONAL SUPPORT; PATHOPHYSIOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; SOCIAL DISABILITY; WEIGHT REDUCTION;

ANOREXIA; CACHEXIA; CONSENSUS; DELPHI TECHNIQUE; ENERGY INTAKE; ENERGY METABOLISM; EXPERT TESTIMONY; FOCUS GROUPS; HUMANS; INTERNATIONAL COOPERATION; MUSCLE STRENGTH; MUSCLE, SKELETAL; NEOPLASMS; SARCOPENIA; SEVERITY OF ILLNESS INDEX; SYNDROME; WEIGHT LOSS;

EID: 79955399340     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(10)70218-7     Document Type: Review

References (48)

1. Moses AWG, Slater C, Preston T, Barber MD, Fearon KCH Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 2004, 90:996-1002.
2. Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 2008, 12:1193-1201.
3. Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980, 69:491-497.
4. Fearon KCH, Voss AC, Hustead DS Definition of cancer cachexia: effect of weight loss, reduced food intake and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006, 83:1345-1350. on behalf of the Cancer Cachexia Study Group.
5. Churm D, Andrew IM, Holden K, Hildreth AJ, Hawkins C A questionnaire study of the approach to the anorexia-cachexia syndrome in patients with cancer by staff in a district general hospital. Support Care Cancer 2009, 17:503-507.
6. Spiro A, Baldwin C, Patterson A, Thomas J, Andreyev HJ The views and practice of oncologists towards nutritional support in patients receiving chemotherapy. Br J Cancer 2006, 95:431-444.
7. Pacelli F, Bossola M, Rosa F, Tortorelli AP, Papa V, Doglietto GB Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery?. Clin Nutr 2008, 27:398-407.
8. Hopkinson JB, Wright DN, McDonald JW, Corner JL The prevalence of concern about weight loss and change in eating habits in people with advanced cancer. J Pain Symptom Manage 2006, 32:322-331.
9. Fearon KC Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer 2008, 44:1124-1132.
10. Kaasa S, Loge JH, Fayers P, et al. Symptom assessment in palliative care: a need for international collaboration. J Clin Oncol 2008, 26:3867-3873.
11. Yavuzsen T, Davis MP, Walsh D, LeGrand S, Lagman R Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol 2005, 23:8500-8511.
12. Bosaeus I Nutritional support in multimodal therapy for cancer cachexia. Support Care Cancer 2008, 16:447-451.
13. Kubrak C, Olson K, Jha N, et al. Nutrition impact symptoms: key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment. Head Neck 2010, 32:290-300.
14. Chopard A, Hillock S, Jasmin BJ Molecular events and signalling pathways involved in skeletal muscle disuse-induced atrophy and the impact of countermeasures. J Cell Mol Med 2009, 13:3032-3050.
15. Paddon-Jones D, Sheffield-Moore M, Cree MG, et al. Atrophy and impaired muscle protein synthesis during prolonged inactivity and stress. J Clin Endocrinol Metab 2006, 91:4836-4841.
16. Reid J, McKenna HP, Fitzsimons D, McCance TV An exploration of the experience of cancer cachexia: what patients and their families want from healthcare professionals. Eur J Cancer Care (Engl) 2010, 19:682-689.
17. Hawkins C, Waterfield K, Hildreth AJ, Kirkpatrick G, Andrew IM Quantifying the impact of standardized assessment and symptom management tools on symptoms associated with cancer-induced anorexia cachexia syndrome. Palliat Med 2009, 23:680-688.
18. Strasser F Appraisal of current and experimental approaches to the treatment of cachexia. Curr Opin Support Palliat Care 2007, 1:312-316.
19. Argilés JM, López-Soriano FJ, Busquets S Mechanisms to explain wasting of muscle and fat in cancer cachexia. Curr Opin Support Palliat Care 2007, 1:293-298.
20. Senior K Why is progress in treatment of cancer cachexia so slow?. Lancet Oncol 2007, 8:671-672.
21. Fox KM, Brooks JM, Gandra SR, Markus R, Chiou CF Estimation of cachexia among cancer patients based on four definitions. J Oncol 2009, published online July 1. 10.1155/2009/693458.
22. Jatoi A Weight loss in patients with advanced cancer: effects, causes, and potential management. Curr Opin Support Palliat Care 2008, 2:45-48.
23. Evans WJ, Morley JE, Argilés J, et al. Cachexia: a new definition. Clin Nutr 2008, 27:793-799.
24. Strasser F Diagnostic criteria of cachexia and their assessment: decreased muscle strength and fatigue. Curr Opin Clin Nutr Metab Care 2008, 11:417-421.
25. Bozzetti F, Mariani L Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group. JPEN J Parenter Enteral Nutr 2009, 33:361-367.
26. Biondo PD, Nekolaichuk CL, Stiles C, Fainsinger R, Hagen NA Applying the Delphi process to palliative care tool development: lessons learned. Support Care Cancer 2008, 16:935-942.
27. Fainsinger RL, Fairchild A, Nekolaichuk C, Lawlor P, Lowe S, Hanson J Is pain intensity a predictor of the complexity of cancer pain management?. J Clin Oncol 2009, 27:585-590.
28. Kitzinger J Qualitative research. Introducing focus groups. BMJ 1995, 311:299-302.
29. Prado CM, Birdsell LA, Baracos VE The emerging role of computerized tomography in assessing cancer cachexia. Curr Opin Support Palliat Care 2009, 3:269-275.
30. Prado CM, Baracos VE, McCargar LJ, et al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 2007, 13:3264-3268.
31. Jette M Guide for Anthropometric Measurements of Canadian Adults 1983, C.T. Management & Consultant, Montreal.
32. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998, 147:755-763.
33. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008, 9:629-635.
34. Janssen I, Heymsfield SB, Ross R Low relative skeletal muscle mass (sarcopenia) in older persons associated with functional impairment and physical disability. J Am Geriatric Soc 2002, 50:889-896.
35. Read JA, Crockett N, Volker DH, et al. Nutritional assessment in cancer: comparing the Mini-Nutritional Assessment (MNA) with the scored Patient-Generated Subjective Global Assessment (PGSGA). Nutr Cancer 2005, 53:51-56.
36. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 2009, 15:6973-6979.
37. Prado CM, Baracos VE, McCargar L, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009, 15:2920-2926.
38. Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics" Clin Nutr 2010, 29:154-159.
39. Lieffers JR, Mourtzakis M, Hall KD, McCargar LJ, Prado CM, Baracos VE A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. Am J Clin Nutr 2009, 89:1173-1179.
40. Orrevall Y, Tishelman C, Permert J, Cederholm T The use of artificial nutrition among cancer patients enrolled in palliative home care services. Palliat Med 2009, 23:556-564.
41. Fearon KC, Barber MD, Moses AG, et al. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol 2006, 24:3401-3407.
42. Strasser F, Lutz TA, Maeder MT, et al. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. Br J Cancer 2008, 98:300-308.
43. Sharma AM, Kushner RF A proposed clinical staging system for obesity. Int J Obes (Lond) 2009, 33:289-295.
44. Yavuzsen T, Walsh D, Davis MP, et al. Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia. Support Care Cancer 2009, 17:1531-1541.
45. Deans DA, Tan BH, Ross JA, et al. Cancer cachexia is associated with the IL10-1082 gene promoter polymorphism in patients with gastroesophageal malignancy. Am J Clin Nutr 2009, 89:1164-1172.
46. Argilés JM, Busquets S, Toledo M, López-Soriano FJ The role of cytokines in cancer cachexia. Curr Opin Support Palliat Care 2009, 3:263-268.
47. Weber MA, Krakowski-Roosen H, Schroder L, et al. Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia. Acta Oncol 2009, 48:116-124.
48. Strasser F, Binswanger J, Cerny T, Kesselring A Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods study. Palliat Med 2007, 21:129-137.